Continuous Processing in Drug Substance Development and Manufacturing | AIChE

Continuous Processing in Drug Substance Development and Manufacturing

Chair(s)

Gerogiorgis, D., University of Edinburgh

Co-chair(s)

Marton, C., Bristol Myers Squibb

Continuous processing for drug substance development and manufacturing continues to be explored by industrial and academic researchers because this mode of operation has several advantages over traditional batch processing. This session focuses on the advancement of continuous processing technology for the manufacture of active pharmaceutical ingredients (API) and intermediates by covering a range of operations from continuous flow reactions to integrated continuous unit operations. Presentations in this session will demonstrate development of continuous flow reactions and their advantages. Additionally, presentations in this session will showcase how key reaction information can be obtained in a resource-sparing manner by combining flow reactors with automation and process analytical technologies. Furthermore, as discussed by several talks in this session, including continuous work-up and isolation unit operations with flow reactors enhances the overall process and gradually leads to the end-to-end continuous manufacturing of API.

Presentations

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing

Individuals

AIChE Pro Members $150.00
AIChE Emeritus Members $105.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $225.00
Non-Members $225.00